Why AI’s Most Promising Near-Term Value Is in Clinical Operations
Update: 2025-08-14
Description
Dimitris Agrafiotis, director of digital analytics and AI at Arsenal Capital Partners sits down with Nagaraja Srivatsan to discuss the current state of AI in clinical trials, the potential for AI to streamline operations, and the importance of user experience and change management in driving adoption of the technology.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
